Newsroom
-
Vertex and Mammoth Biosciences Announce Collaboration to Develop In Vivo Gene-Editing Therapies for Serious Diseases
Business WireLearn More -
Mammoth Biosciences raises $195 million vaulting its CRISPR tech to unicorn status
ForbesLearn More -
Breakout “CRISPR platform” company Mammoth Biosciences is officially a unicorn
TechCrunchLearn More -
Jennifer Doudna’s diagnostic spinout raises Mammoth round as it expands to therapies
Endpoints NewsLearn More -
Mammoth Biosciences Raises $195 Million to Build Next-Generation CRISPR Products in Therapeutics and Diagnostics
Business WireLearn More -